May 2026 $3 M Private placement after listing $2 to $10 million 1
Applied DNA Sciences Inc.: Private sale, May 2026 × Investors in this round 1 investor had bought by the notice of Jun 3, 2026: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $5 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Beth M. Jantzen · Executive Officer Clay D. Shorrock · Executive Officer James D. Haft · Director Joseph D. Ceccoli · Director Joshua D. Kruger · Director Judith D. Murrah · Director Robert B. Catell · Director Yacov A. Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Clay D. Shorrock, President and CEO. Source: SEC Form D, newest notice filed Jun 3, 2026. Read the notice at the SEC .
equity, options SEC Sep 2025 $58 M Private placement after listing $50 to $250 million 33
Applied DNA Sciences Inc.: Private sale, Sep 2025 × Investors in this round 33 investors had bought by the notice of Oct 15, 2025: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $58 M of $58 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $361,745
Finders' fees none
Paid to its own people $725,000 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Beth Jantzen · Executive Officer · Chief Financial Officer Clay Shorrock · Executive Officer · Chief Executive Officer Judith Murrah · Executive Officer, Director · Chairperson of the Board, Strategic Transition Advisor Elizabeth M. Schmalz Shaheen · Director Joseph D. Ceccoli · Director Robert B. Catell · Director Yacov A. Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Lucid Capital Markets, LLC (CRD 000140345) · New York, New York Sold in AZ, CA, CT, FL, IL, KY, NY, PR, TX, VT Remarks in the notice On the amounts: “Reflects estimated proceeds from the sale of shares of the Company's common stock, par value $0.001 per share and/or pre-funded warrants and Series E Warrants, if all Series E Warrants were exercised.”On the use of proceeds: “Includes a total gross amount of (i) $400,000 to be paid in a lump sum to Ms. Murrah on or before November 17, 2025; (ii) $175,000 to be paid as a one-time cash bonus to Mr. Shorrock; and (iii) $150,000 to be paid as a one-time cash bonus to Ms. Jantzen”Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 15, 2025. Read the notice at the SEC .
equity, options SEC Oct 2020 $1 M Private placement after listing Under $2 million 2
Applied DNA Sciences Inc.: Private sale, Oct 2020 × Investors in this round 2 investors had bought by the notice of Oct 20, 2020: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Beth A. Jantzen · Executive Officer · Chief Financial Officer James A. Hayward · Executive Officer, Director · Chairman, CEO and President Judith A. Murrah · Executive Officer · Chief Information Officer Elizabeth M. Schmalz Ferguson · Director John A. Bitzer, III · Director Joseph D. Ceccoli · Director Robert B. Catell · Director Sanford R. Simon · Director Scott D. Anchin · Director Yacov A. Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “On October 7, 2020, 159,000 warrants to purchase common stock were issued at an exercise price of $7.54. Up to 330,500 additional warrants may be issued, at an exercise price determined on the date of issuance, estimated at $7.54.”Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 20, 2020. Read the notice at the SEC .
equity, options SEC Jul 2019 $2 M Private placement after listing Under $2 million 1
Applied DNA Sciences Inc.: Private sale, Jul 2019 × Investors in this round 1 investor had bought by the notice of Jul 19, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Beth A. Jantzen · Executive Officer · Chief Financial Officer James A. Hayward · Executive Officer, Director · Chairman, CEO and President Judith A. Murrah · Executive Officer · Chief Information Officer Charles S. Ryan · Director Elizabeth M. Schmalz Ferguson · Director John A. Bitzer, III · Director Joseph D. Ceccoli · Director Robert B. Catell · Director Sanford R. Simon · Director Yacov A. Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 19, 2019. Read the notice at the SEC .
debt, options SEC Aug 2018 $2 M Private placement after listing Under $2 million 11
Applied DNA Sciences Inc.: Private sale, Aug 2018 × Investors in this round 11 investors had bought by the notice of Sep 4, 2018: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Beth A. Jantzen · Executive Officer · Chief Financial Officer James A. Hayward · Executive Officer, Director · Chairman, CEO and President Judith A. Murrah · Executive Officer · Chief Information Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 4, 2018. Read the notice at the SEC .
debt, options SEC Nov 2016 $5 M Private placement after listing $2 to $10 million 2
Applied DNA Sciences Inc.: Private sale, Nov 2016 × Investors in this round 2 investors had bought by the notice of Nov 14, 2016: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Beth A. Jantzen · Executive Officer · Chief Financial Officer James A. Hayward · Executive Officer, Director Judith A. Murrah · Executive Officer · Chief Information Officer Ming-Hwa Benjamin Liang · Executive Officer · Secretary and Chief Scientific Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Maxim Group (CRD 120708) · New York, New York Sold in NJ, NY Imperial Capital, LLC (CRD 43744) · Los Angeles, California Sold in NJ, NY Remarks in the notice On fees: “7% and 68,182 warrants each to purchase one share of Common Stock”Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 14, 2016. Read the notice at the SEC .
equity, options SEC Jun 2014 $2 M Private placement after listing $2 to $10 million 22
Applied DNA Sciences Inc.: Private sale, Jun 2014 × Investors in this round 22 investors had bought by the notice of Jun 17, 2014: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $5,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people $245,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice James A Hayward · Executive Officer, Director Judy BENJAMIN Murrah · Executive Officer Karol Benjamin Gray · Executive Officer Ming-Hwa Benjamin Liang · Executive Officer Charles Benjamin Ryan · Director John Benjamin Bitzer, Iii · Director Sanford R. Simon · Director Yacov Benjamin Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “INCLUDES WARRANTS AT NO ADDITIONAL CONSIDERATION.”On the use of proceeds: “estimate of proceeds that may be used for salaries of executive officers”Signed by James A. Hayward, Chief executive officer. Source: SEC Form D, newest notice filed Jun 17, 2014. Read the notice at the SEC .
equity, options SEC Jul 2013 $8 M Private placement after listing $2 to $10 million 0
Applied DNA Sciences Inc.: Private sale, Jul 2013 × Investors in this round 0 investors had bought by the notice of Aug 2, 2013: 0 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken $2,000,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people $170,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice James A Hayward · Executive Officer, Director Kurt R. Jensen · Executive Officer Ming-Hwa Benjamin Liang · Executive Officer Charles Benjamin Ryan · Director John Benjamin Bitzer, Iii · Director Karol Benjamin Gray · Director Sanford R. Simon · Director Yacov Benjamin Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “$2 MILLION IN COMMON STOCK HAS BEEN SOLD, AS WELL AS WARRANTS AT NO ADDITIONAL CONSIDERATION. $5.5 MILLION IN NEWLY-CREATED SERIES B CONVERTIBLE PREFERRED STOCK HAS ALSO BEEN SOLD.”Signed by James A. Hayward, Chief executive officer. Source: SEC Form D, newest notice filed Aug 2, 2013. Read the notice at the SEC .
equity, options SEC Nov 2012 $2 M No. 3 $2 to $10 million 0
Applied DNA Sciences Inc.: Raise no. 3, Nov 2012 × Investors in this round 0 investors had bought by the notice of Dec 13, 2012: 0 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $8 M offered; $6 M still to sell
Smallest investment taken $2,000,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James A Hayward · Executive Officer, Director Kurt R. Jensen · Executive Officer Ming-Hwa Benjamin Liang · Executive Officer Charles Benjamin Ryan · Director Gerald Benjamin Catenacci · Director John Benjamin Bitzer, Iii · Director Karol Benjamin Gray · Director Sanford R. Simon · Director Yacov A Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “$2 MILLION IN COMMON STOCK HAS BEEN SOLD, AS WELL AS WARRANTS AT NO ADDITIONAL CONSIDERATION. $5.5 MILLION IN NEWLY-CREATED SERIES A CONVERTIBLE PREFERRED STOCK MAY BE SOLD CONTINGENT ON SATISFACTION OF CERTAIN CONDITIONS.”Signed by Kurt H. Jensen, Chief financial officer. Source: SEC Form D, newest notice filed Dec 13, 2012. Read the notice at the SEC .
equity, options SEC Jun 2012 $2 M No. 2 Under $2 million 1
Applied DNA Sciences Inc.: Raise no. 2, Jun 2012 × Investors in this round 1 investor had bought by the notice of Jul 9, 2012: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $50,000
What was sold equity
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James A. Hayward · Executive Officer, Director Kurt H. Jensen · Executive Officer · Chief Financial Officer Ming-Hwa R. Liang · Executive Officer · Chief Technology Officer and Secretary Charles H. Ryan · Director Gerald H. Catenacci · Director John H. Bitzer, III · Director Karol H. Gray · Director Sanford R. Simon · Director Yacov A. Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No Sales Compensation · Stony Brook, New York Sold in PA Signed by Kurt H. Jensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 9, 2012. Read the notice at the SEC .
equity SEC Jul 2011 $5 M No. 1 $2 to $10 million 6
Applied DNA Sciences Inc.: Raise no. 1, Jul 2011 × Investors in this round 6 investors had bought by the notice of Jul 19, 2011: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $10 M offered; $5 M still to sell
Smallest investment taken $50,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $265,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice James A. Hayward · Executive Officer, Director Kurt H. Jensen · Executive Officer · Chief Financial Officer Ming-Hwa R. Liang · Executive Officer · Chief Technology Officer and Secretary Sanford R. Simon · Director Yacov A. Shamash · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round More than five · broker-dealer HALCYON CABOT PARTNERS, LTD. (CRD 32664) · New York, New York Sold in NY, PA Remarks in the notice On fees: “commission includes a warrant to purchase 7,578,948 shares of common stock.”Signed by Kurt H. Jensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 19, 2011. Read the notice at the SEC .
equity SEC